The process will examine a full range of options to “best position the business for future success”, a company spokesperson told Just Food.

The family behind one of America's most iconic frozen foods found a way to move half a billion dollars of appreciated stock without handing the IRS a dime, and the century-old tax provision they used is now circling Washington like a storm cloud.

GLP-1 patients have cut their grocery budgets by 6%, amounting to $416 in annual shopping hauls per household, a one study.

No one’s reaching for Nesquik and KitKats anymore in our GLP-1 addled-world, so Nestlé is turning to new products.

According to Nestlé’s 2025 annual report, the Swiss giant has six factories in Russia.

STORY: Nestle once saw the rise of GLP-1 weight-loss drugs as a threat. But now… the consumer giant sees an opportunity. Here’s how… :: Richa Naidu, European Consumer Products Correspondent :: August 17, 2026 :: Why does Nestle see opportunity in GLP-1 weight-loss drugs? :: From threat to opportunity :: Protein :: Collagen :: Other nutrients "So when I spoke with Nestle's head of Technology, Stefan Palzer, he said he felt GLP-1 drugs come with a lot of side effects: so, a loss of muscle mass, a loss of bone density, it impacts hair, nails and causes looser skin known as 'Ozempic Face' colloquially. Palzer said Nestle was making products with more protein or collagen and other nutrients to address these side effects, specifically for GLP-1 users." :: How has AI helped Nestle with this approach? "Nestle is using AI to come up with new recipes, to go through scientific research, and conduct market research on whether people will actually buy these products." :: How have nutrition experts responded to these developments "However, nutrition experts have responded to this with a degree of scepticism. The main question being: do people need new packaged food products when there are regular natural products and foods that provide the same kinds of nutrients for a lot cheaper, so I'm thinking eggs, fava beans, chicken, lentils, they all provide protein. There ar e many products that provide the fiber that you need when you're taking these drugs. So, yeah, that's where the scepticism comes from."

The company says AI tools are helping it analyze clinical research and identify nutrients to address side effects like muscle loss

Nestlé (SWX:NESN) shares recently drew investor attention after a fresh look at the company’s financial profile, including its value score, revenue mix, and recent share price performance across different time frames. See our latest analysis for Nestlé. Nestlé’s share price has eased in the short term, with a 1-month share price return of down 3.6%, yet the 1-year total shareholder return of 16.4% points to stronger momentum when dividends are included. If you are comparing Nestlé with other...

Chairman and CEO John Fieldly said “these actions have been evaluated and discussed over the past several months".

Compania Cervecerias Unidas (NYSE:CCU) reported a 59.4% year-over-year increase in consolidated EBITDA for the second quarter of 2026, supported primarily by improved profitability in Chile and a narrower loss in its international business. The company’s wine operation remained under pressure amid w